Luis Miguel
Antón Aparicio
Complejo Asistencial Universitario de Burgos
Burgos, EspañaPublicacións en colaboración con investigadores/as de Complejo Asistencial Universitario de Burgos (4)
2018
-
Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies
Expert Opinion on Drug Safety, Vol. 17, Núm. 6, pp. 573-579
2015
2012
-
MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients
Neoplasia (United States), Vol. 14, Núm. 12, pp. 1144-1152
2004
-
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer
British Journal of Cancer, Vol. 91, Núm. 10, pp. 1758-1762